Biocyll Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 05-07-2024
- Paid Up Capital ₹ 5.00 M
as on 05-07-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 05-07-2024
- Revenue 44.79%
(FY 2023)
- Profit 180.96%
(FY 2023)
- Ebitda 881.13%
(FY 2023)
- Net Worth 905.10%
(FY 2023)
- Total Assets 9.87%
(FY 2023)
About Biocyll Laboratories
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.00 M.
Kishorkumar Patil, Prashant Chaudhari, Mayuri Chaudhari, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC164907
- Company No.
164907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biocyll Laboratories Private Limited offer?
Biocyll Laboratories Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Nitrogen Fertilizers, Fertilizer.
Who are the key members and board of directors at Biocyll Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Chaudhari  | Director | 09-Jun-2016 | Current |
| Kishorkumar Patil | Director | 25-Aug-2020 | Current |
| Mayuri Chaudhari | Director | 06-Sep-2018 | Current |
| Vishal Kittur | Director | 25-Aug-2020 | Current |
Financial Performance of Biocyll Laboratories.
Biocyll Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.79% increase. The company also saw a substantial improvement in profitability, with a 180.96% increase in profit. The company's net worth Soared by an impressive increase of 905.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocyll Laboratories?
In 2023, Biocyll Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jul 2023 | ₹5.00 M | Open |
How Many Employees Work at Biocyll Laboratories?
Unlock and access historical data on people associated with Biocyll Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocyll Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocyll Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
